文献速递中药与中成药合理使用中医内科

四种中药对大鼠氯吡格雷与阿司匹林双联抗血小板治疗的影响

Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats.
PubMed 文献 · J Ethnopharmacol · 2019-01-30

本研究在大鼠中评估丹参、葛根、当归和川芎对氯吡格雷与阿司匹林双联抗血小板治疗药动学和药效学的影响。葛根和当归显著改变阿司匹林和氯吡格雷的药动学,并抑制rCyp2c11和羧酸酯酶活性;葛根、当归和川芎有降低凝血酶原时间的趋势,但未发现出血风险,总体药效学结果不被认为有害。

要点

  • 葛根和当归可显著增加阿司匹林和氯吡格雷的系统暴露。
  • 丹参、葛根和当归显著抑制rCyp2c11和羧酸酯酶活性。
  • 葛根、当归和川芎有抵消抗凝活性的趋势,但无出血风险。

核心结论

  • 葛根和当归合用可改变双联抗血小板治疗的药动学,并显著抑制rCyp2c11和羧酸酯酶活性;虽葛根、当归和川芎可能潜在抵消抗凝活性,但总体药效学结果不被认为有害,因缺乏出血风险,需进一步临床验证。

研究设计与样本

  • 研究为动物实验,使用Sprague-Dawley大鼠,模拟人体双联抗血小板治疗标准给药方案,第1天口服负荷剂量,随后连续13天给药,并同时口服四种中药(丹参、葛根、当归、川芎)的低剂量和高剂量。
  • 第14天给药后系列采血,用LC/MS/MS测定阿司匹林、氯吡格雷及其代谢物血浆浓度;末次采血后采集全血测定凝血酶原时间,处死大鼠取肝脏评估肝微粒体酶活性和表达,取胃组织评估溃疡指数,并用RT-PCR和Western blot检测肝脏COX-1、COX-2、P2Y12的基因表达和蛋白水平。

主要发现

  • 葛根和当归合用分别显著增加阿司匹林和氯吡格雷的系统暴露,改变其药动学。
  • 所有合用中药对阿司匹林酯酶活性影响极小,但丹参、葛根和当归合用显著抑制rCyp2c11和羧酸酯酶活性。
  • 所有双联抗血小板治疗组凝血酶原时间显著延长,但合用葛根、当归和川芎时观察到凝血酶原时间下降趋势。
  • 所有处理均未引起COX和P2Y12 mRNA及蛋白表达的 detectable 变化。

关键数值与推荐

  • 葛根和当归合用显著增加阿司匹林和氯吡格雷的系统暴露。
  • 丹参、葛根和当归合用显著抑制rCyp2c11和羧酸酯酶活性。
  • 所有双联抗血小板治疗组凝血酶原时间显著延长;合用葛根、当归和川芎时凝血酶原时间呈下降趋势。
  • 所有处理未引起COX和P2Y12 mRNA及蛋白表达的 detectable 变化。

临床怎么用

  • 中医及中西医结合医生在患者接受氯吡格雷与阿司匹林双联抗血小板治疗时,应关注葛根和当归可能改变阿司匹林和氯吡格雷的药动学。
  • 合用丹参、葛根和当归可能抑制rCyp2c11和羧酸酯酶活性,需警惕药物相互作用。
  • 葛根、当归和川芎可能潜在抵消抗凝活性,但本研究未发现出血风险,临床影响需进一步验证。

局限性

  • 本研究为大鼠动物实验,结果不能直接外推至人类临床。
  • 研究仅初步评估四种中药对双联抗血小板治疗的影响,临床影响需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Dual antiplatelet therapy (DAPT) with aspirin (ASA) and clopidogrel (CLP) has been consistently shown clinical effectiveness in patients with coronary artery disease. According to the literature, four traditional Chinese medicine (TCM) herbs effective for prevention cardiovascular diseases, namely Radix Salvia Miltiorrhiza (Red sage root, Danshen), Radix Pueraria Lobata (Kudzu root, Gegen), Radix Angelica Sinensis (Angelica root, Danggui), and Rhizoma Ligusticum chuanxiong (Szehuan lovage rhizome, Chuanxiong), are of high potential to be co-administered during DAPT. Since all these herbs are blood vitalizing medicines and can promote blood circulation and eliminate blood stasis, it was hypothesized that they may potentially alter the clinical outcomes of DAPT with clopidogrel and aspirin. AIM OF STUDY: The current study is proposed aiming to preliminarily evaluate the impact of these four commonly used Chinese medicinal herbs on the pharmacokinetics and pharmacodynamics of the combination therapy with clopidogrel and aspirin and its relevant outcomes and mechanisms. MATERIALS AND METHODS: In order to mimic the standard dosing regimen for DAPT in human, various Sprague-Dawley rats treatment groups were received a bolus oral dose of DAPT on day 1 followed by DAPT for consecutive 13 days in absence and presence of orally co-administered four TCM herbs (Danshen, Gegen, Danggui and Chuanxiong) at their low and high doses. On day 14, serial blood samples were collected after dosing to obtain the plasma concentrations of ASA, CLP and their corresponding metabolites by LC/MS/MS. At the end of last blood sampling point of each rat, about 4.5 ml of whole blood were collected to estimate the prothrombin time from each treatment groups. After all the blood sampling, the rats were sacrificed followed by collecting their livers for evaluations of enzyme activities and expressions in the related liver microsome preparations and stomach tissues for evaluations of their potential ulcer index. In addition, gene expression and protein levels of related biomarkers (COX-1, COX-2, P2Y12) in rat livers were measured by RT-PCR and Western blot, respectively, and compared among different treatment groups. RESULTS: Co-administration of Gegen and Danggui significantly altered the pharmacokinetics of ASA and CLP in DAPT with increased systemic exposure of ASA and CLP respectively. Although minimal impact on aspirin esterase activity for all co-administered herbs, significant inhibition on rCyp2c11 and carboxylesterase activities were observed for DAPT with Danshen, Gegen and Danggui co-treatment. In addition, significantly longer PT were found in all DAPT treatment groups. However, a trend of decrease in PT of DAPT in presence of Gegen, Danggui and Chuanxiong was noticed. Nevertheless, all the treatments did not cause detectable changes in COX and P2Y12 mRNA and protein expressions. CONCLUSION: Among the four studied TCMs, it was demonstrated that co-administration of Gegen and Danggui could lead to altered pharmacokinetics of DAPT with significant inhibition on rCyp2c11 and carboxylesterase activities. Although Gegen, Danggui and Chuanxiong might potentially offset the anticoagulant activity of DAPT, the overall pharmacodynamics outcome was not considered to be harmful due to lack of risk in bleeding, which warrant further verification for its clinical impact.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Xiao M, Qian C, Luo X, et al. Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats. J Ethnopharmacol. 2019. PMID: 30710735. doi:10.1016/j.jep.2019.01.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。